Clinical Sessions for Recertification (CE)
Educational Sessions (CE)
Planned in cooperation with the American College of Clinical Pharmacy
ACPE Activity #0204-9999-19-270-L01-P
1.00 Contact Hours | Application-based
The primary focus of this session is to outline the most significant concepts, recommendations, and controversies in the 2018 ACC/AHA High Blood Cholesterol Guideline, with particular emphasis on how to apply the guideline to older patients. There will be a discussion of the four patient groups for whom recommendations for therapy are provided (i.e., clinical ASCVD, severe hypercholesterolemia, diabetes, primary prevention) and analysis of how to evaluate individualized risk and develop collaborative patient care decisions. Treatment decisions in older patients will be emphasized as it relates to risk evaluation and treatment. Additionally, there will be some brief discussion on controversies and newer data that were not incorporated in the guideline. This session will include at least two to three cases highlighting critical aspects of high cholesterol therapy for older patients, where the selection of the most appropriate and evidence-based goal and treatment is discussed.
This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Geriatric Pharmacist (BCGP) recertification credit.